Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
Medical device company Maquet Cardiovascular has filed a complaint against Saphena Medical, a company producing a system known as Venapax, for allegedly infringing its patents.   19 December 2016
Americas
A Boston-based hospital, Brigham and Women’s Hospital, has been awarded $10.2 million in royalty payments after it won a patent case against pharmaceutical company Perrigo.   19 December 2016
Americas
Arent Fox has hired Jay Deshmukh as a partner in the firm's New York office, where he will focus on patent litigation and counselling, particularly for the generic pharmaceutical industry.   16 December 2016
Medtech
Roche has terminated its commercialisation and licensing agreement with Pacific Biosciences for the development and supply of diagnostic products.   16 December 2016
article
At the Life Sciences Patents Network Europe 2016, a conference hosted in London last week by LSIPR, Ednaldo Silva of RoyaltyStat discusses IP licensing in the life sciences industry.   16 December 2016
Americas
Idenix Pharmaceuticals, a subsidiary of Merck, has been awarded $2.5 billion in a patent battle against Gilead over Gilead's drugs Sovaldi and Harvoni, treatments for hepatitis C.   16 December 2016
article
Hearing aid companies that did not convert to 3D printing pills “simply went bust”, says Stella Wong in a video interview with LSIPR at its conference, Life Sciences Patents Network Europe, held in London last week.   15 December 2016
article
In a video interview at Life Sciences Patents Network Europe 2016, a conference hosted in London last week by LSIPR, Marjan Noor of Allen & Overy discusses developments around second medical use patents.   15 December 2016
article
Heli Pihlajamaa, director of patent law at the European Patent Office, gives her advice for plant patent owners last week at the Life Sciences Patents Network Europe, a conference hosted by LSIPR in London.   15 December 2016
Big Pharma
Natalia Gulyaeva and Maria Sedykh of Hogan Lovells look at the main drivers of collaboration in the pharmaceutical sector and the legal issues to keep in mind when handling partnerships in Russia.   15 December 2016